[The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases]. [electronic resource]

By: Contributor(s): Producer: 20060824Description: 697-706 p. digitalISSN:
  • 0025-7753
Subject(s): Online resources: In: Medicina clinica vol. 126
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.